Cracking Cancer Podcast

Ivermectin works by jamming a cellular "door" open that paralyzes parasites. The kicker? Humans don’t even have those doors in our cells. Science! 🧬 Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/zJhK6J1cZ3k

Celebrities claim Ivermectin cures cancer, but doctors are still waiting for a single case report. If the data was there, we’d see it. Crickets. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/zJhK6J1cZ3k

Our long-awaited ivermectin episode is here! @Samantham75074 shares her experience on ivermectin - PhD @scientistswanda and @kyleconcannonmd discuss the science. At CC we believe progress occurs through thoughtful, non-judgmental conversations. Join us! podcasts.apple.com/us/podcast/the…

22,000+ people. 4 days. 1 mission. Our guest’s biggest takeaway from #AACR2026, despite the headlines, the work to solve cancer hasn't stopped for a single day. You aren't fighting this alone. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/vT9wqperii8

Hot Take: We might already have the tools to cure many cancers. The problem? Science incentivizes "new discoveries" over "maximizing current tools." We need to prize implementation as much as innovation. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/vT9wqperii8

The hard truth of oncology: most research never translates to a therapy. But the process is what pushes us forward. #AACR2026 is where the "beautiful chaos" of collaboration happens. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/vT9wqperii8

Max proposes using "Similarity Searches" to match researchers and patients with overlapping data. In 2026, Agentic AI is making this a reality—turning a sea of abstracts into a curated roadmap for a cure. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/vT9wqperii8

The "PhD Gap" at medical conferences is real. Don't try to read every poster. Find the veteran patient advocates who act as "translators." Let them filter the science so you can focus on the hope. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/vT9wqperii8

Not all "breakthroughs" are ready for the clinic. At #AACR2026, much of the data is preclinical—meaning it’s 3-5 years away from helping a patient. The goal is finding the "clinically relevant" truth for today. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/vT9wqperii8

Navigating a major conference like #AACR2026 requires a plan and a filter. Shoutout to the coordinated tracks that help patients find their "tether" without getting lost in the noise. Support ➡️ Giving.CU.EDU/CrackingCancer bit.ly/3OSPKMF

Missed out on ⁦⁦@AACR⁩? ⁦@maxdoppelt⁩ and @kyleconcannonmd discuss attending the annual conference! Major scientific advancements are showcased there every year. A must listen if you plan on attending as a patient/advocate! podcasts.apple.com/us/podcast/the…

Why don't we always radiate the brain in SCLC? Dr. Misty Shields breaks down the "Cognitive Cost" of PCI. In 2026, we’re shifting to targeted radiation (SRS) to protect quality of life. Support ➡️ Giving.CU.EDU/CrackingCancer 🔗youtu.be/0fbg28XR0S0

SCLC research just leaped 40 years forward. Adding immunotherapy previously added 2-3 months. Now, "BiTEs" like Tarlatamab are doubling overall survival in clinical studies. Support ➡️ Giving.CU.EDU/CrackingCancer 🔗youtu.be/0fbg28XR0S0

The "I don't want to be a burden" mindset is the biggest trap in oncology. Matt shares how he tried to go it alone to protect his fiancé, only to realize that isolation helps no one. Bring someone to the room. Support ➡️ Giving.CU.EDU/CrackingCancer 🔗youtu.be/0fbg28XR0S0

"When you grab that first handful of hair, reality slaps you in the face." Matt shares the heavy toll of SCLC treatment—from the trauma of "looking like a patient" to permanent hearing loss from chemo. Support ➡️ Giving.CU.EDU/CrackingCancer 🔗youtu.be/0fbg28XR0S0

Dr. Misty Shields breaks down why Platinum + Etoposide has been the standard since 1985: it damages DNA faster than the cancer can repair it. Catastrophic for the cancer, vital for the patient. Support ➡️ Giving.CU.EDU/CrackingCancer 🔗youtu.be/0fbg28XR0S0

You learn more in one field "workshop" than four semesters in a classroom. Bill shares how patient summits provided more clarity than doctor visits ever could. Support ➡️ Giving.CU.EDU/CrackingCancer 🔗youtu.be/0fbg28XR0S0

For decades, KRAS was considered "undruggable." Here's why that changed & what it means for lung cancer patients Full 3 part series w/ Dr. @FawziAbuRous on YouTube: youtube.com/playlist?list=… Thank you to @RevMedicines for sponsoring YLCI retains editorial control over content

Proton Therapy is the "depth charge" of oncology. Unlike traditional photons, protons dump their energy and STOP, sparing organs behind the tumor. But it’s nuanced. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/Hg4UTm8CI5U

Drugs like Lutathera act as GPS-guided infusions that seek out cancer receptors to deliver radiation directly to the source. Bill’s pro-tip? Hydrate like crazy to manage the systemic side effects. Support ➡️ Giving.CU.EDU/CrackingCancer youtu.be/Hg4UTm8CI5U